Infusystem holdings, inc (INFU)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
OPERATING ACTIVITIES
Net income (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-45,443

0

0

0

Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Provision for doubtful accounts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,099

0

0

0

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,386

0

0

0

Loss on disposal of pumps

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Amortization of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,662

0

0

0

Amortization of deferred debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

238

0

0

0

Stock-based compensation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,185

0

0

0

Deferred income tax expense (benefit)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-23,423

0

0

0

Changes in Assets - (Increase)/Decrease:
Accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,419

0

0

0

Other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

184

0

0

0

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-657

0

0

0

Changes in Liabilities - Increase:
Accounts payable and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,532

0

0

0

NET CASH PROVIDED BY OPERATING ACTIVITIES

13,163

13,875

12,715

10,864

11,607

11,391

11,826

11,333

10,213

7,718

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,452

8,883

6,092

4,609

6,746

0

0

0

INVESTING ACTIVITIES
NET CASH PROVIDED BY OPERATING ACTIVITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,404

5,136

8,783

7,054

8,436

9,236

6,499

7,255

6,902

7,036

5,195

7,463

0

0

0

-

-

-

-

-

-

-

-

Purchase of medical equipment and property

0

-

0

0

0

-

4,344

3,502

2,757

2,652

933

-193

2,842

5,101

1,805

1,911

3,802

4,198

0

0

0

-

-

-

-

-

5,626

6,142

6,223

6,542

9,228

8,792

7,869

8,211

0

0

0

Purchases of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,995

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of medical equipment and property

2,688

2,952

3,214

2,932

3,128

3,319

2,692

2,963

3,296

3,866

4,828

4,617

4,462

3,821

4,406

4,445

4,260

4,494

4,273

4,738

6,733

6,867

6,185

6,079

3,959

3,800

3,265

3,159

4,146

3,978

0

0

0

-

-

-

-

NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,903

-5,883

-11,745

-11,907

-13,553

-13,703

-5,515

-2,838

-3,549

-1,843

-1,353

-2,162

0

0

0

-

-

-

-

-

-

-

-

NET CASH USED IN INVESTING ACTIVITIES

-20,908

-19,643

-16,988

-10,521

-7,590

-4,984

-1,948

-835

243

918

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,558

-1,681

-2,221

-3,860

-5,127

0

0

0

FINANCING ACTIVITIES
Principal payments on term loans, equipment line, revolving credit facility and other financing

13,168

4,868

5,186

4,867

4,458

6,319

6,745

16,755

33,843

37,466

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash proceeds from 2019 equipment line and revolving credit facility

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash proceeds from bank loans and revolving credit facility

-

-

-

-

-

-

-

-

-

28,866

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments on revolving credit facility, term loans and capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

56,718

50,806

41,391

65,202

70,269

76,796

91,475

66,689

25,693

21,065

16,096

4,504

30,796

22,231

10,320

9,631

11,738

9,686

7,803

5,953

0

0

0

Cash proceeds from revolving credit facility

-

-

-

-

-

-

-

-

-

-

-

-

-

-

55,151

51,458

41,530

70,429

74,644

81,201

93,570

61,853

0

0

0

-

-

-

-

37,101

0

0

0

-

-

-

-

Debt issuance costs

-

6

0

0

0

-

-

-

-

38

0

0

0

-

-

-

-

157

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments on term loan and seller's note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Common stock repurchased as part of Repurchase Program

-

-

-

-

-

10,395

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

363

0

0

0

Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans

1,106

717

0

0

0

-

-

-

-

58

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash proceeds - stock plans

273

252

237

113

98

91

91

90

90

131

210

165

166

204

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock - issued

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,418

761

307

5,156

4,204

4,217

1,744

-5,040

-2,359

-4,254

-3,818

-6,489

0

0

0

-

-

-

-

-

-

-

-

NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

6,150

4,097

3,548

-1,002

-3,647

-5,558

-6,799

-8,213

-9,120

-8,565

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,367

-6,171

-4,790

-3,925

-5,834

0

0

0

Net change in cash and cash equivalents

-1,595

-1,671

-725

-659

370

849

3,079

2,285

1,336

71

-269

-729

-375

2,580

83

14

-2,655

303

-913

-250

2,728

-623

994

939

24

-1,188

-556

-702

472

1,527

1,031

-919

-3,176

-4,215

0

0

0

SUPPLEMENTAL DISCLOSURES
Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,934

0

0

0

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

249

0

0

0

NON-CASH TRANSACTIONS
Additions to medical equipment and property

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,008

0

0

0

Medical equipment acquired pursuant to a capital lease

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,300

0

0

0

Gross issuance of vested restricted shares (number of shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

402

119

25